Literature DB >> 29543130

Effects of cerebral small vessel disease on the outcome of patients with ischemic stroke caused by large artery atherosclerosis.

Hui Zhu1, Zhixing Li1, Jinglei Lv2, Renliang Zhao2.   

Abstract

OBJECTIVE: Cerebral small vessel disease (CSVD) describes a syndrome of neuroimaging, pathological, and associated clinical features caused by small intracranial vascular lesions, which commonly coexists with large artery atherosclerosis (LAA) and has been identified as a major cause of motor impairment over time. In this review, we aim to summarize the relationship between CSVD and LAA, and discuss the effects of CSVD on the clinical outcome of patients with ischemic stroke caused by LAA.
METHODS: We searched and scanned all the literature with the keyword cerebral small vessel disease, cerebral microbleeds, white matter hyperintensity, silent lacunar infarcts, enlarged perivascular spaces and stroke in the database of Pubmed and MEDLINE (from inception to 1 February 2015).
RESULTS: Various imaging phenotypes of CSVDs have different influences on the clinical outcome of patients with LAA stroke. The total brain burden of CSVD can represent the cumulative effects of different MRI features of CSVD, which has predictive value for recurrent stroke after ischemic stroke. Better quantification of the total brain burden of CSVD may help stratify patients more effectively in clinical practice. DISCUSSION: CSVD can significantly influence the clinical outcome of stroke in patients with cerebral infarction caused by LAA, and the methods to capture whole brain CSVD burden cross the spectrum of changes in CSVD imaging features may be useful for patient stratification in clinical trials. Further studies should be performed to validate the relationship between CSVD related brain damage and LAA stroke.

Entities:  

Keywords:  Cerebral small vessel disease; ischemic stroke; large artery atherosclerosis; magnetic resonance imaging; neurological function

Mesh:

Year:  2018        PMID: 29543130     DOI: 10.1080/01616412.2018.1446283

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  5 in total

1.  Association between serum anti‑ASXL2 antibody levels and acute ischemic stroke, acute myocardial infarction, diabetes mellitus, chronic kidney disease and digestive organ cancer, and their possible association with atherosclerosis and hypertension.

Authors:  Shu-Yang Li; Yoichi Yoshida; Eiichi Kobayashi; Akihiko Adachi; Seiichiro Hirono; Tomoo Matsutani; Seiichiro Mine; Toshio Machida; Mikiko Ohno; Eiichiro Nishi; Yoshiro Maezawa; Minoru Takemoto; Koutaro Yokote; Kenichiro Kitamura; Makoto Sumazaki; Masaaki Ito; Hideaki Shimada; Hirotaka Takizawa; Koichi Kashiwado; Go Tomiyoshi; Natsuko Shinmen; Rika Nakamura; Hideyuki Kuroda; Xiao-Meng Zhang; Hao Wang; Kenichiro Goto; Yasuo Iwadate; Takaki Hiwasa
Journal:  Int J Mol Med       Date:  2020-07-29       Impact factor: 4.101

Review 2.  Aryl hydrocarbon receptor pathway: Role, regulation and intervention in atherosclerosis therapy (Review).

Authors:  Kaixi Zhu; Qingqi Meng; Zhi Zhang; Tao Yi; Yuan He; Jing Zheng; Wei Lei
Journal:  Mol Med Rep       Date:  2019-10-16       Impact factor: 2.952

3.  Serum anti-AP3D1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis.

Authors:  Shu-Yang Li; Yoichi Yoshida; Eiichi Kobayashi; Masaaki Kubota; Tomoo Matsutani; Seiichiro Mine; Toshio Machida; Yoshiro Maezawa; Minoru Takemoto; Koutaro Yokote; Yoshio Kobayashi; Hirotaka Takizawa; Mizuki Sata; Kazumasa Yamagishi; Hiroyasu Iso; Norie Sawada; Shoichiro Tsugane; Sohei Kobayashi; Kazuyuki Matsushita; Fumio Nomura; Hisahiro Matsubara; Makoto Sumazaki; Masaaki Ito; Satoshi Yajima; Hideaki Shimada; Katsuro Iwase; Hiromi Ashino; Hao Wang; Kenichiro Goto; Go Tomiyoshi; Natsuko Shinmen; Rika Nakamura; Hideyuki Kuroda; Yasuo Iwadate; Takaki Hiwasa
Journal:  Sci Rep       Date:  2021-06-29       Impact factor: 4.379

4.  Nomogram to predict risk for early ischemic stroke by non-invasive method.

Authors:  Shuliang Chen; Chunye Ma; Ce Zhang; Rui Shi
Journal:  Medicine (Baltimore)       Date:  2020-09-25       Impact factor: 1.817

5.  MicroRNA-155 influences cell damage in ischemic stroke via TLR4/MYD88 signaling pathway.

Authors:  Wei Chen; Lingtong Wang; Zhaoping Liu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.